IRCT20200513047423N6尚未招募未知
Bioequivalance study of Fexofenadine 180 mg Tablets manufactured by Sana Med pharmaceutical company on 24 healthy volunteers and comparing pharmacokinetics results with Telfast Tablets manufactured by Abidi-SANOFI
Sana Med0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- All
入选标准
- •Healthy liver
- •Healthy kidney
- •Volunteers should not be too fat or too thin and their weight index should be in the appropriate range
排除标准
- •Out of age ranges
研究者
相似试验
尚未招募
不适用
Bioequivalence evaluation of Fexofenadine Tablet 180 mg manufactured by Raha pharmaceutical companyIRCT20200625047913N6Hezareh Sevom Futuristic Pharmacist24
已完成
1 期
Bioequivalence Study of Dr.Reddy's Fexofenadine Hydrochloride 180 mg Tablets Under Fasting ConditionsHealthyNCT01066754Dr. Reddy's Laboratories Limited44
已完成
1 期
Bioequivalence Study of Dr. Reddy's Laboratories Limited Fexofenadine Hydrochloride 180 mg Tablets Under Fed ConditionsHealthyNCT01066767Dr. Reddy's Laboratories Limited30
尚未招募
不适用
Comparative in vivo evaluation of 2 Fexofenadin 30 mg/5 ml Suspension formulations.IRCT20180620040164N42Darou darman Pars Co.24
已完成
Unknown
Comparative bioequivalence study of the Fexofenadine Hydrichloride 180 mg, tablet manufactured by Tasnim CompanyIRCT20130313012810N16Tasnim24